Publikationen
-
2026
Heitmann, J. S., Maringer, Y., Jung, S. et al. Personalized multi-peptide-based T cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study. Lancet Haematology (2026).
The Lancet Haematology